Financial Gravity Companies, Inc. Novartis Ag Transaction History
Financial Gravity Companies, Inc.
- $509 Billion
- Q2 2025
A detailed history of Financial Gravity Companies, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Financial Gravity Companies, Inc. holds 44,198 shares of NVS stock, worth $5.81 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
44,198
Previous 38,243
15.57%
Holding current value
$5.81 Million
Previous $3.72 Billion
43.72%
% of portfolio
1.05%
Previous 0.85%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,603Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...